CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2010-07-02): Infection nearly quadruples mortality in cirrhosis patients

Epidemiology

Infection nearly quadruples mortality in cirrhosis patients

Last Updated: 2010-07-02 18:30:46 -0400 (Reuters Health)

NEW YORK (Reuters Health) - When cirrhotic patients develop infections, their death rate rises dramatically, European researchers have found.

They have "a worse prognosis even if the infection resolves," senior author Dr. Andrew K. Burroughs from the Royal Free Hospital in London told Reuters Health by e-mail.

In a meta-analysis of studies involving nearly 12,000 patients with cirrhosis, he and his colleagues found that infections prompt an almost fourfold increase in mortality.

The analysis, reported online June 16th in Gastroenterology, included 178 studies with 225 cohorts. The median age was 56, 47% had alcoholic cirrhosis and 39% had hepatitis B or C.

Eighteen studies had relevant data to compare survival in infected versus non-infected patients; 40.4% of the 1135 patients with infection died during follow-up, compared to 19.5% of the 2317 without infection (p = 0.00001, pooled odds ratio 3.75).

As reported in 101 studies, 7062 patients had spontaneous bacterial peritonitis. Their one- and 12-month median mortality rates were 32.5% and 66.2%, respectively.

Among 1437 patients (from 30 studies) with bacteremia, mortality rates were 42.2% and 67.4% at one and 12 months, respectively.

Out of 225 cohorts, only 35 (15.4%) reported prophylactic use of antibiotics, and then only in a median of 7.7% of patients.

Although there were not enough data for a proper evaluation, prophylaxis was associated with reduced mortality from spontaneous bacterial peritonitis (37% versus 43.2%).

In studies conducted after 2000, "there was no significant improvement for mortality at one year, for those surviving the first month...compared to the previous 20 years," the researchers say.

"For infection, in contrast to variceal bleeding, there has not been an improvement in survival over several decades," they write.

Cirrhosis is usually described as compensated in its early stages and decompensated as liver failure develops. Perhaps, the authors suggest, the "critically ill cirrhotic" should be a new prognostic stage.

http://www.gastrojournal.org/article/S0016-5085(10)00878-4/abstract

Gastroenterology 2010.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.